NOVARTIND — Novartis India Balance Sheet
0.000.00%
Last trade - 00:00- IN₹33.71bn
- IN₹27.06bn
- IN₹3.54bn
Annual balance sheet for Novartis India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5,163 | 5,544 | 5,850 | 6,371 | 6,684 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,276 | 591 | 648 | 618 | 371 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,078 | 6,773 | 6,993 | 7,458 | 7,683 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 237 | 193 | 69.4 | 45.4 | 28.8 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 9,576 | 9,829 | 9,249 | 9,478 | 9,783 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,164 | 1,595 | 1,572 | 1,421 | 1,450 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,659 | 2,073 | 1,801 | 1,629 | 1,604 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Total Equity | 6,917 | 7,757 | 7,448 | 7,850 | 8,178 |
| Total Liabilities & Shareholders' Equity | 9,576 | 9,829 | 9,249 | 9,478 | 9,783 |
| Total Common Shares Outstanding |